Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...
The risk to the general public from bird flu is low, and there has been no further evidence of person to person spread, ...
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...
The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
To address the rising bird flu cases, the US government has committed $590 million to fast-track Moderna's mRNA bird flu ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine.